Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Amortization of Deferred Charges (2017 - 2022)

Inspire Medical Systems' Amortization of Deferred Charges history spans 6 years, with the latest figure at $62000.0 for Q1 2022.

  • For Q1 2022, Amortization of Deferred Charges rose 6.9% year-over-year to $62000.0; the TTM value through Mar 2022 reached $244000.0, up 7.02%, while the annual FY2021 figure was $240000.0, 7.14% up from the prior year.
  • Amortization of Deferred Charges for Q1 2022 was $62000.0 at Inspire Medical Systems, roughly flat from $62000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $213000.0 in Q1 2018 and bottomed at $51000.0 in Q2 2019.
  • The 5-year median for Amortization of Deferred Charges is $59000.0 (2021), against an average of $80117.6.
  • The largest annual shift saw Amortization of Deferred Charges soared 249.18% in 2018 before it crashed 59.52% in 2019.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $112000.0 in 2018, then plummeted by 51.79% to $54000.0 in 2019, then increased by 7.41% to $58000.0 in 2020, then grew by 6.9% to $62000.0 in 2021, then changed by 0.0% to $62000.0 in 2022.
  • Per Business Quant, the three most recent readings for INSP's Amortization of Deferred Charges are $62000.0 (Q1 2022), $62000.0 (Q4 2021), and $61000.0 (Q3 2021).